Biden administration’s restrict on drug marketplace middlemen backfires, pharmacists say

Biden administration’s restrict on drug marketplace middlemen backfires, pharmacists say

Credit history: Unsplash/CC0 Public Domain The Biden administration’s initially big stage toward imposing limitations on the pharmacy advantage managers who act as the drug industry’s value negotiators is backfiring, pharmacists…

Read More »